MK-677 (Ibutamoren): The Oral GH Secretagogue That Actually Works (With Caveats)

MK-677 is a growth hormone secretagogue that is a selective agonist of the ghrelin receptor (GHSR).

What is MK-677?

MK-677 is a growth hormone secretagogue studied under the full name Ibutamoren. Researchers usually discuss it in the context of growth hormone secretagogue, with attention to mechanism, dose range, safety signals, and product quality. This profile separates compound-specific research notes from vendor claims and personal protocol decisions. It also links the profile to product research context. The page should be read as research context, not personal medical guidance.

How does MK-677 work?

MK-677 works through the pathway described in its product research data: MK-677 is a selective agonist of the ghrelin receptor (GHSR). This binding action stimulates the pituitary gland to secrete growth hormone in a pulsatile manner, similar to the body's natural rhythm but with increased amplitude and frequency. This leads to a significant and durable increase in circulating levels of both GH and Insulin-like Growth Factor 1 (IGF-1) without significantly affecting cortisol levels. The practical question is whether that pathway matches the claimed outcome. Mechanistic plausibility can support a hypothesis, but it does not replace controlled human evidence, safety monitoring, or legal review.

What are the benefits of MK-677?

The commonly discussed benefits of MK-677 include significantly increases growth hormone (gh) and igf-1 levels, promotes the development of lean muscle mass, enhances lipolysis (fat breakdown), improves sleep quality and rem sleep duration, increases bone mineral density. These benefits should be interpreted through the evidence source behind each claim. A product page may summarize use cases, but a research decision should check whether the endpoint came from human data, animal data, or mechanism-based reasoning.

What are the side effects of MK-677?

Reported or plausible side effects for MK-677 include increased appetite and hunger (very common), mild lethargy or fatigue, especially upon waking, water retention and potential for mild edema in extremities, possible decrease in insulin sensitivity with long-term use, numbness or tingling in hands/feet (paresthesia). Injection-site reactions, tolerance issues, glucose changes, appetite changes, sleep changes, or hormone-marker shifts can matter depending on the compound class. Stop criteria and medical review matter more when symptoms persist or worsen.

Is MK-677 legal?

MK-677 may be sold by vendors for research use only, but that label does not make human use legal or medically appropriate. FDA status, prescription rules, import rules, customs rules, and WADA rules can differ. A compound can be lawful for one research or prescription context and prohibited in sport. Competitive athletes should check the current prohibited list before handling any peptide or related compound.

Dosing context

Research discussions commonly list 10-25 mg at 1x daily for 8-16 weeks. Those values are not instructions. Dose interpretation depends on route, purity, lot testing, half-life, medical history, and the endpoint being tracked. Best taken orally on an empty stomach before bed. This timing aligns with the body's natural GH pulse during sleep and helps mitigate potential side effects like lethargy.

Research and monitoring notes

Track objective outcomes that match the mechanism. For MK-677, that may include symptom logs, training load, body weight, appetite, sleep, glucose, IGF-1, inflammation markers, or injury-specific measures depending on the research question. Avoid adding multiple new compounds at once, because adverse effects and benefits become hard to attribute.

Product comparison context

The matching product page can help compare vendor-facing details, but the research profile should come first. Read the mechanism, safety notes, legal context, and references before comparing price or availability.